Renub Research

www.renub.com
Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis

Published: December, 2012

Copyright 2012 Renub Research All Rights Reserved

Pediatric Vaccines Market Analysis

Worldwide pediatric vaccine market has been growing rapidly over the last five years as it has doubled its market share in 2011 compared to 2005. The worldwide pediatrics vaccine market is expected to be more than US$ 23 Billion by 2015 growing with a single digit CAGR during 2012 2015. This incremental growth has been due to blockbuster vaccines (Prevnar7, Prevnar 13, Rotarix and Rotateq) sales in Billion of US$ which made a significant contribution. It is predicted that Pediatric proprietary vaccines will lead the segment with little less than 60% market share by 2015.The combinations & boosters and enhanced pediatric vaccines market are expected to show stagnant growth in future due to lower margins and the mature nature of these markets. Pneumococcal, DTP and Varicella together all these three vaccines control 55% of the market share in 2011. In number of cases Polio, Haemophiilus Influenzae Type B (HIB) and MMR cases have shown decline continuously from the year 2001 till 2011. Polio remains endemic merely in three countries and the good news is that India has not reported a single case from the past two years and on the verge of being called a polio free country. DTP are the most utilized vaccines in the pediatric vaccines market which contributed less than 10,000 Million doses in 2011. Pediatric Hepatitis and Polio vaccines are also mostly used vaccines which consumed more than 6,000 Million doses in 2011. In case of Rotavirus vaccine although the price of Rotavirus vaccine has declined but still its present prices are expensive than other pediatric vaccines. However despite all the impediments pediatric vaccines industry is expected to remain highly active in the future, fueled by the encouragement and financing from governments and other health organizations. Renub Research report titled "Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis talks about the pediatric vaccines. The report provides information on all the Nine (9) Pediatric Vaccines Market, Doses, Immunization and Number of Cases by region in the world. This report covers in detail all aspects of past, present and future scenario. This report provides market landscape and market share information of the Pediatric Combinations & Booster, Pediatric Enhanced Combination and Pediatric Proprietary

Renub Research

Page 2 of 19

Vaccines Market. The report also entails major factors driving the pediatric vaccine market and challenges of pediatric vaccine market. Pediatric Vaccines Covered in this Report are as follows: Measles, Mumps & Rubella (MMR) Vaccines, Haemophilus Influenzae Type B (HIB) Vaccines, Polio Vaccines, Diphtheria, Tetanus & Pertussis (Combos) Vaccines, Pneumococcal Vaccines Rotavirus Vaccines, Hepatitis Pediatric Vaccines, Varicella/Chicken Pox Vaccines and Other Pediatric Vaccines All the Pediatric Vaccines in this Report have been Studied from Four View Points: Number of Cases Reported for all 9 Pediatric Diseases by Region from 2001 to 2011 Number of Doses Reported and Forecast for all 9 Pediatric Vaccine from 2005 to 2015 Immunization Coverage for all 9 Pediatric Vaccines and Forecast from 2005 to 2015 Market Size for all 9 Pediatric Vaccines and Forecast from 2005 to 2015

Key Topics Covered in the Report Worldwide Pediatric Vaccines Market and Forecast (2006 - 2015) Worldwide Pediatric Vaccines Market Share and Forecast (Sector wise) (2005 - 2015) Worldwide Pediatric Vaccines Market Share & Forecast (Disease wise) (2006 - 2015) By Sector (All 9) Pediatric Vaccines Market and Forecast (2005 - 2015) By Region - Pediatric Disease Cases (2001 2011) Pediatric Vaccines Doses and Forecast (2005 2015) Pediatric Vaccines Immunization Coverage and Forecast (2005 - 2015) All 9 Pediatric Vaccines Market and Forecast (2005 - 2015) Growth Drivers of Pediatric Vaccines Market Challenges of Pediatric Vaccines Market

Renub Research

Page 3 of 19

Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts. Primary sources include industry surveys and telephone interviews with industry experts. Secondary sources information and data has been collected from various printable and nonprintable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 100 paid databases.

Renub Research

Page 4 of 19

About Us
Renub Research
is a leading Market Research and Information Analysis Company with

centers at Noida India and Roswell USA. We have long-term experience especially in international Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others. Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research help make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in todays ultra-competitive markets.

For more information on us or to view any of our sample work you can mail us at info@renub.com

Renub Research

Page 5 of 19

Published By

Renub Research
A116B, Sector27 Noida 201301 Phone: +91-120-421-9822, 254-5750 (India) +1-678-302-0700 (USA) Fax : +91-120-424-9780 Email: info@renub.com www.renub.com

Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis Renub Research, 2012 Edition 1.0 All rights reserved. This publication is protected by copyright. No part of it may be reproduced, stored in a retrieval system or transmitted, in any form or by any means, electronic mechanical, photocopying, recording or otherwise without the prior written permission of the publishers

Renub Research

Page 6 of 19

Table of Contents
1. 2. 3. 4. 5. Executive Summary Worldwide Pediatric Vaccines Market and Forecast (2006 2015) Worldwide Pediatric Vaccines Market Share & Forecast (Sector wise) (2005 2015) Worldwide Pediatric Vaccines Market Share & Forecast (Disease wise) (2006 2015) By Sector Pediatric Vaccines Market and Forecast (2005 2015) 5.1 5.2 5.3 6. Worldwide Pediatric Combinations & Boosters Vaccines Market Worldwide Pediatric Enhanced Combinations Vaccines Market Worldwide Pediatric Proprietary Vaccines Market

Major Pediatric Vaccines Cases, Doses, Immunization Coverage, Market and Forecast 6.1 Measles, Mumps & Rubella (MMR) Vaccines and Forecast (2005 2015) Number of Measles, Mumps & Rubella Cases (2001 2011) Number of Measles, Mumps & Rubella (MMR) Vaccines Doses Immunization Coverage of Measles, Mumps & Rubella (MMR) Vaccines Market Size of Measles, Mumps & Rubella (MMR) Vaccines

6.1.1 6.1.2 6.1.3 6.1.4 6.2

Haemophilus Influenzae Type B (HIB) Vaccines and Forecast (2005 2015) Number of Haemophilus Influenzae Type B (HIB) Meningitis Cases (2001 2011) Number of Haemophilus Influenzae Type B (HIB) Vaccines Doses Immunization Coverage of Haemophilus Influenzae Type B (HIB) Vaccines Market Size of Haemophilus Influenzae Type B (HIB) Vaccines

6.2.1 6.2.2 6.2.3 6.2.4 6.3

Polio Vaccines and Forecast (2005 2015) Number of Polio Cases (2001 2011) Number of Polio Vaccines Doses Immunization Coverage of Polio Vaccines Market Size of Polio Vaccines

6.3.1 6.3.2 6.3.3 6.3.4 6.4

Diphtheria, Tetanus & Pertussis (Combos) Vaccines and Forecast (2005 2015) Number of Diphtheria, Tetanus & Pertussis (DTP) Cases (2001 2011) Number of Diphtheria, Tetanus & Pertusis (DTP) Vaccines Doses Immunization Coverage of Diphtheria, Tetanus & Pertusis (DTP) Vaccines Market Size of Diphtheria, Tetanus & Pertussis (Combos) Vaccines

6.4.1 6.4.2 6.4.3 6.4.4 6.5

Pneumococcal Vaccines and Forecast (2005 2015)

Renub Research

Page 7 of 19

6.5.1 6.5.2 6.5.3 6.5.4 6.6

Number of Pneumococcal Cases (2000) Number of Pneumococcal Vaccines Doses Immunization Coverage of Pneumococcal Vaccines Market Size of Pneumococcal Vaccines

Rotavirus Vaccine and Forecast (2006 2015) Number of Rotavirus Cases (2008 & 2009) Number of Rotavirus Vaccines Doses Immunization Coverage of Rotavirus Vaccines Market Size of Rotavirus Vaccine

6.6.1 6.6.2 6.6.3 6.6.4 6.7

Hepatitis Pediatric Vaccines and Forecast (2005 2015) Number of Hepatitis Pediatric Vaccines Doses Immunization Coverage of Hepatitis Pediatric Vaccines Market Size of Hepatitis Pediatric Vaccines

6.7.1 6.7.2 6.7.3 6.8

Varicella/Chicken Pox Vaccines and Forecast (2005 2015) Number of Varicella/Chicken Pox Vaccines Doses Market Size of Varicella/Chicken Pox Vaccines

6.8.1 6.8.2 6.9

Other Pediatric Vaccines and Forecast (2005 2015) Market Size of Other Pediatric Vaccines

6.9.1 7.

Growth Drivers of Pediatric Vaccines Market 7.1 Reduced Price on Rotavirus Vaccines: Enough to Facilitate Growth but More Still Needs To Be Rotavirus Vaccine Introduction Financial Challenges Cost Effective Future Steps Conclusion

Done Error! Bookmark not defined. 7.1.1 7.1.2 7.1.3 7.1.4 7.1.5 7.2

GAVI Model Increases Vaccine Manufacturers The Partnership Model The Business Model

7.2.1 7.2.2 7.3 8.

WHO Global Vaccine Action Plan (2011 - 2020)

Challenges of Pediatric Vaccine Market 8.1 8.2 Roadblocks in Expanding Access to Newer Pediatric Vaccines Impediment in Pediatric Vaccine Research & Development

Renub Research

Page 8 of 19

8.3

Barriers to New Entrants in the Pediatric Vaccines Market

Renub Research

Page 9 of 19

List of Figures
Figure 2-1: Worldwide Pediatric Vaccines Market (Million US$), 2006 2011 Figure 2-2: Worldwide Forecast for Pediatric Vaccines Market (Million US$), 2012 2015 Figure 3-1: Worldwide (Sector wise) Pediatric Vaccines Market Share (Percent), 2005 2011 Figure 3-2: Worldwide (Sector wise) Forecast for Pediatric Vaccines Market Share (Percent), 2012 2015 Figure 5-1: Worldwide Pediatric Combinations & Boosters Vaccines Market (Million US$), 2005 2011 Figure 5-2: Worldwide Forecast for Pediatric Combinations & Boosters Vaccines Market (Million US$), 2012 2015 Figure 5-3: Worldwide Pediatric Enhanced Combinations Vaccines Market (Million US$), 2005 2011 Figure 5-4: Worldwide Forecast for Pediatric Enhanced Combinations Vaccines Market (Million US$), 2012 2015 Figure 5-5: Worldwide Pediatric Proprietary Vaccines Market (Million US$), 2005 2011 Figure 5-6: Worldwide Forecast for Pediatric Proprietary Vaccines Market (Million US$), 2012 2015 Figure 6-1: Worldwide Number of MMR Vaccines Doses (Million Doses), 2005 2011 Figure 6-2: Worldwide Forecast for Number of MMR Vaccines Doses (Million Doses), 2012 2015 Figure 6-3: Worldwide Immunization Coverage of MMR Vaccines Doses (Million Doses), 2005 2011 Figure 6-4: Worldwide Forecast for Immunization Coverage of MMR Vaccines Doses (Million Doses), 2012 2015 Figure 6-5: Worldwide Measles, Mumps & Rubella Vaccines Market (Million US$), 2005 2011 Figure 6-6: Worldwide Forecast for Measles, Mumps & Rubella Vaccines Market (Million US$), 2012 2015 Figure 6-7: Worldwide Haemophilus Influenzae Type B Vaccine Introduction in High & Low-Income Countries, 1980 2010 Figure 6-8: Worldwide Number of Doses of Haemophilus Influenzae Type B Vaccines (Million Doses), 2005 2011 Figure 6-9: Worldwide Forecast for Number of Doses of Haemophilus Influenzae Type B Vaccines (Million Doses), 2012 2015 Figure 6-10: Worldwide Immunization Coverage of Haemophilus Influenzae Type B Vaccines (Million Doses), 2005 2011 Figure 6-11: Worldwide Forecast for Immunization Coverage of Haemophilus Influenzae Type B Vaccines (Million Doses), 2012 2015 Figure 6-12: Worldwide Haemophilus Influenzae Type B (HIB) Vaccines Market (Million US$), 2005 2011 Figure 6-13: Worldwide Forecast for Haemophilus Influenzae Type B (HIB) Vaccines Market (Million US$), 2012 2015

Renub Research

Page 10 of 19

Figure 6-14: Worldwide Number of Doses of Polio Vaccines (Million Doses), 2005 2011 Figure 6-15: Worldwide Forecast for Number of Doses of Polio Vaccines (Million Doses), 2012 2015 Figure 6-16: Worldwide Immunization Coverage of Polio Vaccines (Million Doses), 2005 2011 Figure 6-17: Worldwide Forecast for Immunization Coverage of Polio Vaccines (Million Doses), 2012 2015 Figure 6-18: Worldwide Polio Vaccines Market (Million US$), 2005 2011 Figure 6-19: Worldwide Forecast for Polio Vaccines Market (Million US$), 2012 2015 Figure 6-20: Worldwide Number of Doses of DTP Vaccines (Million Doses), 2005 2011 Figure 6-21: Worldwide Forecast for Number of Doses of DTP Vaccines (Million Doses), 2012 2015 Figure 6-22: Worldwide Immunization Coverage of DTP Vaccines (Million Doses), 2005 2011 Figure 6-23: Worldwide Forecast for Immunization Coverage of DTP Vaccines (Million Doses), 2012 2015 Figure 6-24: Worldwide Diphtheria, Tetanus & Pertussis (Combos) Vaccines Market (Million US$), 2005 2011 Figure 6-25: Worldwide Forecast for Diphtheria, Tetanus & Pertussis (Combos) Vaccines Market (Million US$), 2012 2015 Figure 6-26: Worldwide Pneumococcal Vaccine Pipeline, 2000 2025 Figure 6-27: Worldwide Number of Doses of Pneumococcal Vaccines (Million Doses), 2010 2011 Figure 6-28: Worldwide Forecast for Number of Doses of Pneumococcal Vaccines (Million Doses), 2012 2015 Figure 6-29: Worldwide Immunization Coverage of Pneumococcal Vaccines (Million Doses), 2010 2011 Figure 6-30: Worldwide Forecast for Immunization Coverage of Pneumococcal Vaccines (Million Doses), 2012 2015 Figure 6-31: Worldwide Pneumococcal Vaccines Market (Million US$), 2005 2011 Figure 6-32: Worldwide Forecast for Pneumococcal Vaccines Market (Million US$), 2012 2015 Figure 6-33: Worldwide Number of Doses of Rotavirus Vaccines (Million Doses), 2010 2011 Figure 6-34: Worldwide Forecast for Number of Doses of Rotavirus Vaccines (Million Doses), 2012 2015 Figure 6-35: Worldwide Immunization Coverage of Rotavirus Vaccines (Million Doses), 2010 2011 Figure 6-36: Worldwide Forecast for Immunization Coverage of Rotavirus Vaccines (Million Doses), 2012 2015 Figure 6-37: Worldwide Rotavirus Vaccine Market (Million US$), 2006 2011 Figure 6-38: Worldwide Forecast for Rotavirus Vaccine Market (Million US$), 2012 2015 Figure 6-39: Worldwide Number of Doses of Hepatitis Pediatric Vaccines (Million Doses), 2005 2011 Figure 6-40: Worldwide Forecast for Number of Doses of Hepatitis Pediatric Vaccines (Million Doses), 2012 2015

Renub Research

Page 11 of 19

Figure 6-41: Worldwide Immunization Coverage of Hepatitis Pediatric Vaccines (Million Doses), 2005 2011 Figure 6-42: Worldwide Forecast for Immunization Coverage of Hepatitis Pediatric Vaccines (Million Doses), 2012 2015 Figure 6-43: Worldwide Hepatitis B Vaccine Introduction in High & Low-income countries, 1980 2010 Figure 6-44: Worldwide Hepatitis Pediatric Vaccines Market (Million US$), 2005 2011 Figure 6-45: Worldwide Forecast for Hepatitis Pediatric Vaccines Market (Million US$), 2012 2015 Figure 6-46: Worldwide Number of Doses of Varicella Vaccines (Million Doses), 2005 2011 Figure 6-47: Worldwide Forecast for Number of Doses of Varicella Vaccines (Million Doses), 2012 2015 Figure 6-48: Worldwide Varicella Vaccines Market (Million US$), 2005 2011 Figure 6-49: Worldwide Forecast for Varicella Vaccines Market (Million US$), 2012 2015 Figure 6-50: Worldwide Other Pediatric Vaccines Market (Million US$), 2005 2011 Figure 6-51: Worldwide Forecast for Other Pediatric Vaccines Market (Million US$), 2012 2015 Figure 7-1: Prices of Childhood Vaccines (US$), 2011 Figure 7-2: Reduction in Rotavirus Vaccine Prices (US$), May 2011 & April 2012 Figure 7-3: Increasing Number of GAVI Suppliers Based in Emerging Markets

Renub Research

Page 12 of 19

List of Tables
Table 4-1: Worldwide (Disease wise) Pediatric Vaccines Market Share (Percent), 2006 2011 Table 4-2: Worldwide (Disease wise) Forecast for Pediatric Vaccines Market Share (Percent), 2012 2015 Table 6-1: Worldwide (By Geographic Region) Number of Measles Cases (Number), 2001 2011 Table 6-2: Worldwide (By Geographic Region) Number of Mumps Cases (Number), 2001 2011 Table 6-3: Worldwide (By Geographic Region) Number of Rubella Cases (Number), 2001 2011 Table 6-4: Worldwide (By Geographic Region) Number of Haemophilus Influenzae Type B Meningitis Cases (Number), 2001 2011 Table 6-5: Worldwide (By Geographic Region) Number of Polio Cases (Number), 2001 2011 Table 6-6: Worldwide (By Geographic Region) Number of Diphtheria Cases (Number), 2001 2011 Table 6-7: Worldwide (By Geographic Region) Number of nTetanus Cases (Number), 2001 2011 Table 6-8: Worldwide (By Geographic Region) Number of tTetanus Cases (Number), 2001 2011 Table 6-9: Worldwide (By Geographic Region) Number of Pertusis Cases (Number), 2001 2011 Table 6-10: Worldwide (By Geographic Region) Pneumococcal Cases & Death in Children Under 5 Years of Age (Number), 2000 Table 6-11: Worldwide (By Geographic Region) WHO Coordinated Rotavirus Surveillance (Number), 2008 2009 Table 6-12: Worldwide (By Geographic Region) WHO Coordinated Rotavirus Surveillance Positive Cases (Number & Percent), 2009 Table 7-1: Worldwide Total Future Deaths Averted through Vaccination (Million), 2011 2020 Table 7-2: Goal-Level Indicators, 2015 & 2020

Renub Research

Page 13 of 19

Order Form
Scan and e-mail this page to info@renub.com, alternatively one can also write the Contact Information in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780 Questions? Please call +91-120-421-9822 (India), +1-678-302-0700 (USA) or mail to info@renub.com

Format
Report Title: Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis

Single User (Email from Publisher) US$ 1,400

Hard Copy (Mail Delivery) US$ 1,550

CD Rom (Mail Delivery) US$ 1,500

Global Site License (Multiple User License) US$ 2,200

For ordering this report: Three easy ways to place your order:
1) Order online by Credit Card (Visa, MasterCard, etc.): http://www.renub.com/reports/showdetails.aspx?id=86 2) Order by Wire Transfer: http://www.renub.com/reports/wiretransfer.aspx?id=86&pid=1325 To pay by Wire Transfer, please, fill in your contact details in the form below:

Renub Research

Page 14 of 19

Bank Details
Account Name: Renub Research A/C No.: 109102000023296 Name of Bank: IDBI Bank Ltd. Swift Code: IBKLINBB010 Bank Address: 4th Floor Indian Red Cross Building 1 Red Cross Road Opposite Parliament Street New Delhi 110001 India

Contact Information
First Name: Email: Job Title: Company: Address: City: Postal/Zip Code: Country: Phone: Mobile: Fax: Report Format: Your message: Last Name:

Renub Research

Page 15 of 19

3) Order by Check Please post the check accompanied by this form, to: Company Address: Renub Research A -116B Sector -27 Noida - 201301 Uttar Pradesh India Phone: +91-120-421-9822, 424-9780

For free Sample copy report or to view any of our sample work please contact us at info@renub.com or call +91-120-421-9822 (India), +1-678-302-0700 (USA)

Follow Us
Facebook: http://www.facebook.com/pages/Renub-Research/233380966701090 LinkedIn: http://www.linkedin.com/company/renub-research Twitter: http://twitter.com/RenubResearch

Renub Research

Page 16 of 19

Related Reports
Western Europe (EU-16) In Vitro Diagnostics Market Report & Forecast (2012 2015) Clinical Chemistry Market Report & Forecast (2012 2015): Global Analysis Philippines Medical Tourist Arrivals, Medical Tourism Market & Forecast to 2015 India Medical Tourist Arrivals, Medical Tourism Market & Forecast to 2015 Singapore Medical Tourist Arrivals, Medical Tourism Market & Forecast to 2015 Thailand Medical Tourist Arrivals, Medical Tourism Market & Forecast to 2015 Hepatitis C (HCV) Market Forecast & Drugs Pipeline Analysis to 2016 Influenza Vaccine Market Opportunities and Challenges: Worldwide Forecast Genetic Testing Market and Forecast - Global Analysis 2010 2015 USA Cardiovascular Devices Market Trends and Forecast (2010 2015) Global Osteoporosis Market & Drugs Analysis 2010 2015 Global Schizophrenia Prevalence, Companies Analysis & Drugs Forecast (2010 2015) Global Molecular Diagnostics Market & Future Forecast 2010 - 2014 Alzheimers Disease Patients & Market Worldwide, Future Scenario (2010 2015) & Drugs Analysis Global Cardiovascular Surgery Devices Market Trends and Future Forecast (2009 - 2014)

Renub Research

Page 17 of 19

Our Partial List of Clients

Redbus Becton Dickinson Pfizer Intercell Sanofi Pasteur Stanford Burgess Pequot Capital DMI Transgene S.A. ixia communications Toyota Tsusho Amercia Inc. National Health Research Institutes Abbott Diabetes Care Corning Incorporated - Life Sciences L.E.K. Consulting GmbH Syntiron MediVas LLC Credit Suisse Dune Medical QIAGEN Inje University Mapp Biopharmaceutical Institute for Information Industry NorDiag ASA Renub Research Rep e Inv Medicas SA de Innogenetics Page 18 of 19

Bain WAKE Technology Services, Inc. PSS World Medical Relypsa C&K components Konkuk University Resonetics Samsung SEKISUI MEDICAL CO. LTD. Plentyoffish Media INC Arthur D Little Gmbh Morgan Stanley Takeda Pharmaceutical Corporation Hokkai School of Commerce Ministry of Manpower Singapore GenOmind, LLC. Goldman Sachs & Co NTT Advanced Technology Tokyo Womens Medical University The Chemo-Sero-Therapeutic Research Trade Council of Iceland Jpmorgan, Ets Trading GE Healthcare IT ixia communications

Disclaimer
This research report is published by Renub Research. All rights reserved. Reproduction or redistribution of this research report in any form for any business purpose is expressly prohibited without written permission of www.renub.com and any payments of a specified fee. Requests to republish any material may be sent to us at info@renub.com. Most of the information available in this report is within the public domain. The submitting authors or other copyright holders retain rights for reproduction or redistribution. All persons reproducing or redistributing this information are expected to adhere to the terms and constraints invoked by the copyright holder. Such protected material, however, may be used under the terms of "fair use as defined in the copyright laws, which generally permit use for non-commercial educational purposes such as teaching, research, criticism, and news reporting. With respect to documents available, neither the company nor any of its employees makes any warranty, express or implied, including the warranties of merchantability and fitness for a particular purpose, or assumes any legal liability or responsibility for the accuracy, completeness, or usefulness of any information, apparatus, product, or process disclosed, or represents that its use would not infringe privately owned rights.

Renub Research

Page 19 of 19